ASCO 2024: Immunotherapy for the Treatment of Small Cell Lung Cancer - Episode 13
Closing Thoughts and Key Takeaways on Small Cell Lung Cancer
In a forward-looking discussion, Ticiana Leal, MD; Anne Chiang, MD, PhD; Afshin Dowlati, MD; and Tarita O. Thomas, MD, PhD, offer their concluding insights on the evolving landscape of clinical trials and the future directions of small cell lung cancer (SCLC) treatment, highlighting promising areas of research and potential breakthroughs that may shape the management of this challenging disease in the years to come.
Video content above is prompted by the following question:
- What are your final perspectives and insights on unmet needs and therapeutic advances in SCLC?
Related Content:
